Purchase Order HHSD2002016M90008P
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Biomerieux Inc. for a "BIOMERIEUX FULL SERVICE PLAN" with a potential value of $55,853.99. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics and provides a range of proprietary microbiology analyzers, reagents, and test kits to support infectious disease testing and pathogen detection for federal...
- This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Biomerieux Inc., a global leader in in vitro diagnostics. The $242,002.88 contract is for a service and preventative maintenance agreement for Biomerieux's laboratory instruments. The contract does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. division, provides a range of clinical diagnostic equipment, reagents, and supplies to various federal agencies,...
- This is a firm-fixed-price delivery order contract awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Biomerieux Inc. for BIO-MERIEUX MAINTENANCE SERVICE. The contract has a ceiling value of $96,673.56 and a period of performance through April 30, 2022. The contract does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, is a global leader in in vitro diagnostics and specializes in microbiological testing...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for VCI SCAN RDI NEW GENERATION with a completion date of September 30, 2018. The potential value of the contract is $321,220.99. The contract was not set aside for any specific business category. Biomerieux Inc. is a worldwide leader in in vitro diagnostics, providing...
- The U.S. federal agency Office of Administrative Services Procurement Management Branch awarded a firm-fixed-price Purchase Order to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of MasterClave equipment for the Midwestern Lab. The contract, valued at $148,421.76, has a completion date of September 5, 2025. Biomerieux Inc. is a foreign-owned, for-profit manufacturer providing specialized diagnostic platforms and consumables to support infectious disease testing and...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biomerieux Inc., a global leader in in vitro diagnostics. The $16,822.90 contract is for the supply of Biomerieux reagents and supports CDC operations in Atlanta, Georgia. Biomerieux is a manufacturer of clinical diagnostic equipment, reagents, and supplies used for infectious disease testing and pathogen detection across healthcare, food safety, and industrial testing programs. The...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products and services. The $144,184.32 contract is for a service maintenance agreement, with a performance period from May 2017 to May 2022. Biomerieux Inc. provides a range of clinical diagnostic testing products, equipment, and services, including proprietary...
- This $3,271,440.00 firm-fixed-price definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Biomerieux Inc., a global in vitro diagnostics company, for BIONUMERICS SUPPORT services. The contract has a period of performance through July 31, 2025 and does not involve any set-aside designations. Biomerieux Inc., through its Biomerieux, Inc. division, is a leading provider of specialized clinical diagnostic equipment, reagents, and supplies to various federal...
- This federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, is for the supply of the company's proprietary diagnostic platforms, reagents, test kits, and maintenance services to various government healthcare operations. The contract has a ceiling value of $30,228 and is a firm fixed-price purchase order with a completion date of May 31, 2026. The award was issued by the Office of Logistics and Acquisition Operations, a civilian agency. Biomerieux Inc. has been...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc. for a maintenance agreement with a base year completion date of September 23, 2022. The contract has a ceiling value of $110,081.87 and does not utilize any set-aside designations. Biomerieux Inc., a global leader in in vitro diagnostics, is providing specialized diagnostic equipment, reagents, test kits, and maintenance services, primarily focused on infectious disease testing...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biomerieux Inc. for preventive maintenance of EasyMag and EasyQ instruments. The contract has a ceiling value of $131,600.28 and a period of performance ending on May 31, 2021. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics, providing a range of clinical diagnostic equipment, reagents, and supplies to various federal agencies. The company holds several significant federal contract Indefinite Delivery Vehicles, including a $194 million Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits, as well as Blanket Purchase Agreements with the Department of Veterans Affairs and the Indian Health Service. These contract vehicles facilitate ongoing procurement of Biomerieux's proprietary diagnostic platforms and consumables by government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 7 | Other Administrative Action | ($5k) | 2/27/23 | |
| 6 | Exercise an Option | $17.9k | 11/27/19 | |
| 5 | Exercise an Option | $17.6k | 5/1/19 | |
| 4 | Exercise an Option | $17.2k | 4/17/18 | |
| 3 | Other Administrative Action | $0 | 10/19/17 |